dazmegrel has been researched along with Arterial Occlusive Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franklin, A; Friedman, M; Johnson, RG; Sellke, FW; Wang, SY; Weintraub, RM | 1 |
| Gewirtz, H; Most, AS; Sasken, H; Steiner, M | 1 |
2 other study(ies) available for dazmegrel and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Pulmonary injury after total or partial cardiopulmonary bypass with thromboxane synthesis inhibition.
Topics: Animals; Arterial Occlusive Diseases; Blood Proteins; Cardiopulmonary Bypass; Heart Atria; Imidazoles; Lymph; Platelet Aggregation Inhibitors; Platelet Count; Preoperative Care; Pulmonary Artery; Pulmonary Circulation; Reperfusion Injury; Sheep; Thromboxanes; Vascular Resistance | 1995 |
Impaired arteriolar vasodilation induced by thrombosis of a coronary arterial stenosis.
Topics: Animals; Arterial Occlusive Diseases; Aspirin; Coronary Circulation; Heart Rate; Hemodynamics; Imidazoles; Lactates; Lactic Acid; Prostaglandin Endoperoxides, Synthetic; Regional Blood Flow; Swine; Thrombosis; Thromboxane A2; Vascular Resistance; Vasodilation | 1985 |